3.3.1.900 html 483 530 1 true 153 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://immunepharmaceuticals.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - Consolidated Balance Sheets Sheet http://immunepharmaceuticals.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 103 - Statement - Consolidated Balance Sheets [Parenthetical] Sheet http://immunepharmaceuticals.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets [Parenthetical] Statements 3 false false R4.htm 104 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://immunepharmaceuticals.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 105 - Statement - Consolidated Statement of Stockholders' Equity Sheet http://immunepharmaceuticals.com/role/ConsolidatedStatementOfStockholdersEquity Consolidated Statement of Stockholders' Equity Statements 5 false false R6.htm 106 - Statement - Consolidated Statement of Stockholders' Equity (Parenthetical) Sheet http://immunepharmaceuticals.com/role/ConsolidatedStatementOfStockholdersEquityParenthetical Consolidated Statement of Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 107 - Statement - Consolidated Statements of Cash Flows Sheet http://immunepharmaceuticals.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 108 - Disclosure - NATURE OF OPERATIONS Sheet http://immunepharmaceuticals.com/role/NatureOfOperations NATURE OF OPERATIONS Notes 8 false false R9.htm 109 - Disclosure - GOING CONCERN UNCERTAINTY, FINANCIAL CONDITION AND MANAGEMENT'S PLANS Sheet http://immunepharmaceuticals.com/role/GoingConcernUncertaintyFinancialConditionAndManagementsPlans GOING CONCERN UNCERTAINTY, FINANCIAL CONDITION AND MANAGEMENT'S PLANS Notes 9 false false R10.htm 110 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 111 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS Sheet http://immunepharmaceuticals.com/role/DerivativeFinancialInstruments DERIVATIVE FINANCIAL INSTRUMENTS Notes 11 false false R12.htm 112 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://immunepharmaceuticals.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 12 false false R13.htm 113 - Disclosure - LICENSING AGREEMENTS Sheet http://immunepharmaceuticals.com/role/LicensingAgreements LICENSING AGREEMENTS Notes 13 false false R14.htm 114 - Disclosure - INTANGIBLE ASSETS Sheet http://immunepharmaceuticals.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 14 false false R15.htm 115 - Disclosure - ACCRUED EXPENSES Sheet http://immunepharmaceuticals.com/role/AccruedExpenses ACCRUED EXPENSES Notes 15 false false R16.htm 116 - Disclosure - NOTES AND LOANS PAYABLE Notes http://immunepharmaceuticals.com/role/NotesAndLoansPayable NOTES AND LOANS PAYABLE Notes 16 false false R17.htm 117 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://immunepharmaceuticals.com/role/StockholdersEquity STOCKHOLDERS' EQUITY Notes 17 false false R18.htm 118 - Disclosure - SERIES D PREFERRED STOCK Sheet http://immunepharmaceuticals.com/role/SeriesDPreferredStock SERIES D PREFERRED STOCK Notes 18 false false R19.htm 119 - Disclosure - LOSS PER SHARE Sheet http://immunepharmaceuticals.com/role/LossPerShare LOSS PER SHARE Notes 19 false false R20.htm 120 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://immunepharmaceuticals.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 20 false false R21.htm 121 - Disclosure - INCOME TAXES Sheet http://immunepharmaceuticals.com/role/IncomeTaxes INCOME TAXES Notes 21 false false R22.htm 122 - Disclosure - 2014 FINANCINGS Sheet http://immunepharmaceuticals.com/role/Financings 2014 FINANCINGS Notes 22 false false R23.htm 123 - Disclosure - RELATED-PARTY TRANSACTIONS Sheet http://immunepharmaceuticals.com/role/RelatedpartyTransactions RELATED-PARTY TRANSACTIONS Notes 23 false false R24.htm 124 - Disclosure - Subsequent Events Sheet http://immunepharmaceuticals.com/role/SubsequentEvents Subsequent Events Notes 24 false false R25.htm 125 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 126 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPolicies 26 false false R27.htm 127 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Tables) Sheet http://immunepharmaceuticals.com/role/DerivativeFinancialInstrumentsTables DERIVATIVE FINANCIAL INSTRUMENTS (Tables) Tables http://immunepharmaceuticals.com/role/DerivativeFinancialInstruments 27 false false R28.htm 128 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://immunepharmaceuticals.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://immunepharmaceuticals.com/role/FairValueMeasurements 28 false false R29.htm 129 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://immunepharmaceuticals.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://immunepharmaceuticals.com/role/IntangibleAssets 29 false false R30.htm 130 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://immunepharmaceuticals.com/role/AccruedExpensesTables ACCRUED EXPENSES (Tables) Tables http://immunepharmaceuticals.com/role/AccruedExpenses 30 false false R31.htm 131 - Disclosure - NOTES AND LOANS PAYABLE (Tables) Notes http://immunepharmaceuticals.com/role/NotesAndLoansPayableTables NOTES AND LOANS PAYABLE (Tables) Tables http://immunepharmaceuticals.com/role/NotesAndLoansPayable 31 false false R32.htm 132 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://immunepharmaceuticals.com/role/StockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://immunepharmaceuticals.com/role/StockholdersEquity 32 false false R33.htm 133 - Disclosure - SERIES D PREFERRED STOCK (Tables) Sheet http://immunepharmaceuticals.com/role/SeriesDPreferredStockTables SERIES D PREFERRED STOCK (Tables) Tables http://immunepharmaceuticals.com/role/SeriesDPreferredStock 33 false false R34.htm 134 - Disclosure - LOSS PER SHARE (Tables) Sheet http://immunepharmaceuticals.com/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://immunepharmaceuticals.com/role/LossPerShare 34 false false R35.htm 135 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://immunepharmaceuticals.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://immunepharmaceuticals.com/role/CommitmentsAndContingencies 35 false false R36.htm 136 - Disclosure - INCOME TAXES (Tables) Sheet http://immunepharmaceuticals.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://immunepharmaceuticals.com/role/IncomeTaxes 36 false false R37.htm 137 - Disclosure - GOING CONCERN UNCERTAINTY, FINANCIAL CONDITION AND MANAGEMENTS PLANS (Details Textual) Sheet http://immunepharmaceuticals.com/role/GoingConcernUncertaintyFinancialConditionAndManagementsPlansDetailsTextual GOING CONCERN UNCERTAINTY, FINANCIAL CONDITION AND MANAGEMENTS PLANS (Details Textual) Details http://immunepharmaceuticals.com/role/GoingConcernUncertaintyFinancialConditionAndManagementsPlans 37 false false R38.htm 138 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesTables 38 false false R39.htm 139 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesDetails1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Details http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesTables 39 false false R40.htm 140 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) Sheet http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) Details http://immunepharmaceuticals.com/role/SummaryOfSignificantAccountingPoliciesTables 40 false false R41.htm 141 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details) Sheet http://immunepharmaceuticals.com/role/DerivativeFinancialInstrumentsDetails DERIVATIVE FINANCIAL INSTRUMENTS (Details) Details http://immunepharmaceuticals.com/role/DerivativeFinancialInstrumentsTables 41 false false R42.htm 142 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details 1) Sheet http://immunepharmaceuticals.com/role/DerivativeFinancialInstrumentsDetails1 DERIVATIVE FINANCIAL INSTRUMENTS (Details 1) Details http://immunepharmaceuticals.com/role/DerivativeFinancialInstrumentsTables 42 false false R43.htm 143 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details Textual) Sheet http://immunepharmaceuticals.com/role/DerivativeFinancialInstrumentsDetailsTextual DERIVATIVE FINANCIAL INSTRUMENTS (Details Textual) Details http://immunepharmaceuticals.com/role/DerivativeFinancialInstrumentsTables 43 false false R44.htm 144 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://immunepharmaceuticals.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://immunepharmaceuticals.com/role/FairValueMeasurementsTables 44 false false R45.htm 145 - Disclosure - FAIR VALUE MEASUREMENTS (Details 1) Sheet http://immunepharmaceuticals.com/role/FairValueMeasurementsDetails1 FAIR VALUE MEASUREMENTS (Details 1) Details http://immunepharmaceuticals.com/role/FairValueMeasurementsTables 45 false false R46.htm 146 - Disclosure - FAIR VALUE MEASUREMENTS (Details 2) Sheet http://immunepharmaceuticals.com/role/FairValueMeasurementsDetails2 FAIR VALUE MEASUREMENTS (Details 2) Details http://immunepharmaceuticals.com/role/FairValueMeasurementsTables 46 false false R47.htm 147 - Disclosure - FAIR VALUE MEASUREMENTS (Details 3) Sheet http://immunepharmaceuticals.com/role/FairValueMeasurementsDetails3 FAIR VALUE MEASUREMENTS (Details 3) Details http://immunepharmaceuticals.com/role/FairValueMeasurementsTables 47 false false R48.htm 148 - Disclosure - FAIR VALUE MEASUREMENTS (Details 4) Sheet http://immunepharmaceuticals.com/role/FairValueMeasurementsDetails4 FAIR VALUE MEASUREMENTS (Details 4) Details http://immunepharmaceuticals.com/role/FairValueMeasurementsTables 48 false false R49.htm 149 - Disclosure - FAIR VALUE MEASUREMENTS (Details Textual) Sheet http://immunepharmaceuticals.com/role/FairValueMeasurementsDetailsTextual FAIR VALUE MEASUREMENTS (Details Textual) Details http://immunepharmaceuticals.com/role/FairValueMeasurementsTables 49 false false R50.htm 150 - Disclosure - LICENSING AGREEMENTS (Details Textual) Sheet http://immunepharmaceuticals.com/role/LicensingAgreementsDetailsTextual LICENSING AGREEMENTS (Details Textual) Details http://immunepharmaceuticals.com/role/LicensingAgreements 50 false false R51.htm 151 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://immunepharmaceuticals.com/role/IntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://immunepharmaceuticals.com/role/IntangibleAssetsTables 51 false false R52.htm 152 - Disclosure - INTANGIBLE ASSETS (Details 1) Sheet http://immunepharmaceuticals.com/role/IntangibleAssetsDetails1 INTANGIBLE ASSETS (Details 1) Details http://immunepharmaceuticals.com/role/IntangibleAssetsTables 52 false false R53.htm 153 - Disclosure - INTANGIBLE ASSETS (Details Textual) Sheet http://immunepharmaceuticals.com/role/IntangibleAssetsDetailsTextual INTANGIBLE ASSETS (Details Textual) Details http://immunepharmaceuticals.com/role/IntangibleAssetsTables 53 false false R54.htm 154 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://immunepharmaceuticals.com/role/AccruedExpensesDetails ACCRUED EXPENSES (Details) Details http://immunepharmaceuticals.com/role/AccruedExpensesTables 54 false false R55.htm 155 - Disclosure - NOTES AND LOANS PAYABLE (Details) Notes http://immunepharmaceuticals.com/role/NotesAndLoansPayableDetails NOTES AND LOANS PAYABLE (Details) Details http://immunepharmaceuticals.com/role/NotesAndLoansPayableTables 55 false false R56.htm 156 - Disclosure - NOTES AND LOANS PAYABLE (Details 1) Notes http://immunepharmaceuticals.com/role/NotesAndLoansPayableDetails1 NOTES AND LOANS PAYABLE (Details 1) Details http://immunepharmaceuticals.com/role/NotesAndLoansPayableTables 56 false false R57.htm 157 - Disclosure - NOTES AND LOANS PAYABLE (Details Textual) Notes http://immunepharmaceuticals.com/role/NotesAndLoansPayableDetailsTextual NOTES AND LOANS PAYABLE (Details Textual) Details http://immunepharmaceuticals.com/role/NotesAndLoansPayableTables 57 false false R58.htm 158 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://immunepharmaceuticals.com/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details http://immunepharmaceuticals.com/role/StockholdersEquityTables 58 false false R59.htm 159 - Disclosure - STOCKHOLDERS' EQUITY (Details 1) Sheet http://immunepharmaceuticals.com/role/StockholdersEquityDetails1 STOCKHOLDERS' EQUITY (Details 1) Details http://immunepharmaceuticals.com/role/StockholdersEquityTables 59 false false R60.htm 160 - Disclosure - STOCKHOLDERS' EQUITY (Details 2) Sheet http://immunepharmaceuticals.com/role/StockholdersEquityDetails2 STOCKHOLDERS' EQUITY (Details 2) Details http://immunepharmaceuticals.com/role/StockholdersEquityTables 60 false false R61.htm 161 - Disclosure - STOCKHOLDERS' EQUITY (Details 3) Sheet http://immunepharmaceuticals.com/role/StockholdersEquityDetails3 STOCKHOLDERS' EQUITY (Details 3) Details http://immunepharmaceuticals.com/role/StockholdersEquityTables 61 false false R62.htm 162 - Disclosure - STOCKHOLDERS' EQUITY (Details 4) Sheet http://immunepharmaceuticals.com/role/StockholdersEquityDetails4 STOCKHOLDERS' EQUITY (Details 4) Details http://immunepharmaceuticals.com/role/StockholdersEquityTables 62 false false R63.htm 163 - Disclosure - STOCKHOLDERS' EQUITY (Details Textual) Sheet http://immunepharmaceuticals.com/role/StockholdersEquityDetailsTextual STOCKHOLDERS' EQUITY (Details Textual) Details http://immunepharmaceuticals.com/role/StockholdersEquityTables 63 false false R64.htm 164 - Disclosure - SERIES D PREFERRED STOCK (Details) Sheet http://immunepharmaceuticals.com/role/SeriesDPreferredStockDetails SERIES D PREFERRED STOCK (Details) Details http://immunepharmaceuticals.com/role/SeriesDPreferredStockTables 64 false false R65.htm 165 - Disclosure - SERIES D PREFERRED STOCK (Details Textual) Sheet http://immunepharmaceuticals.com/role/SeriesDPreferredStockDetailsTextual SERIES D PREFERRED STOCK (Details Textual) Details http://immunepharmaceuticals.com/role/SeriesDPreferredStockTables 65 false false R66.htm 166 - Disclosure - LOSS PER SHARE (Details) Sheet http://immunepharmaceuticals.com/role/LossPerShareDetails LOSS PER SHARE (Details) Details http://immunepharmaceuticals.com/role/LossPerShareTables 66 false false R67.htm 167 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://immunepharmaceuticals.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://immunepharmaceuticals.com/role/CommitmentsAndContingenciesTables 67 false false R68.htm 168 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Textual) Sheet http://immunepharmaceuticals.com/role/CommitmentsAndContingenciesDetailsTextual COMMITMENTS AND CONTINGENCIES (Details Textual) Details http://immunepharmaceuticals.com/role/CommitmentsAndContingenciesTables 68 false false R69.htm 169 - Disclosure - INCOME TAXES (Details) Sheet http://immunepharmaceuticals.com/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://immunepharmaceuticals.com/role/IncomeTaxesTables 69 false false R70.htm 170 - Disclosure - INCOME TAXES (Details 1) Sheet http://immunepharmaceuticals.com/role/IncomeTaxesDetails1 INCOME TAXES (Details 1) Details http://immunepharmaceuticals.com/role/IncomeTaxesTables 70 false false R71.htm 171 - Disclosure - INCOME TAXES (Details 2) Sheet http://immunepharmaceuticals.com/role/IncomeTaxesDetails2 INCOME TAXES (Details 2) Details http://immunepharmaceuticals.com/role/IncomeTaxesTables 71 false false R72.htm 172 - Disclosure - INCOME TAXES (Details 3) Sheet http://immunepharmaceuticals.com/role/IncomeTaxesDetails3 INCOME TAXES (Details 3) Details http://immunepharmaceuticals.com/role/IncomeTaxesTables 72 false false R73.htm 173 - Disclosure - INCOME TAXES (Details Textual) Sheet http://immunepharmaceuticals.com/role/IncomeTaxesDetailsTextual INCOME TAXES (Details Textual) Details http://immunepharmaceuticals.com/role/IncomeTaxesTables 73 false false R74.htm 174 - Disclosure - 2014 FINANCINGS (Details Textual) Sheet http://immunepharmaceuticals.com/role/FinancingsDetailsTextual 2014 FINANCINGS (Details Textual) Details http://immunepharmaceuticals.com/role/Financings 74 false false R75.htm 175 - Disclosure - RELATED-PARTY TRANSACTIONS (Details Textual) Sheet http://immunepharmaceuticals.com/role/RelatedpartyTransactionsDetailsTextual RELATED-PARTY TRANSACTIONS (Details Textual) Details http://immunepharmaceuticals.com/role/RelatedpartyTransactions 75 false false R76.htm 176 - Disclosure - Subsequent Events (Details Textual) Sheet http://immunepharmaceuticals.com/role/SubsequentEventsDetailsTextual Subsequent Events (Details Textual) Details http://immunepharmaceuticals.com/role/SubsequentEvents 76 false false All Reports Book All Reports imnp-20151231.xml imnp-20151231.xsd imnp-20151231_cal.xml imnp-20151231_def.xml imnp-20151231_lab.xml imnp-20151231_pre.xml true true